apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Avastimab 100mg Injection
  3. Avastimab 100mg Injection Substitute

Avastimab 100mg Injection Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

BEVACIZUMAB-100MG

Uses:

Avastimab 100mg Injection is used in the treatment of Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. The detailed uses of Avastimab 100mg Injection are as follows:<br/>• Colorectal Cancer: Avastimab 100mg Injection is used in combination with chemotherapy for metastatic cases.<br/>• Non-Small Cell Lung Cancer (NSCLC): Avastimab 100mg Injection helps slow tumor growth and spread when combined with carboplatin and paclitaxel.<br/>• Ovarian, Cervical, and Peritoneal Cancer: Avastimab 100mg Injection is often used post-surgery or with chemotherapy to improve outcomes.<br/>• Renal Cell Carcinoma (Kidney Cancer): Avastimab 100mg Injection enhances treatment efficacy when paired with other agents.<br/>• Glioblastoma (Brain Tumor): Avastimab 100mg Injection is approved for recurrent cases to reduce tumor vascularization.<br/>• Hepatocellular Carcinoma (Liver Cancer): Avastimab 100mg Injection is used in combination with other drugs for advanced stages.<br/>

Medicinal Benefits:

Avastimab 100mg Injection contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Avastimab 100mg Injection works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.

FAQs

Avastimab 100mg Injection is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum.

Avastimab 100mg Injection works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Avastimab 100mg Injection helps treat cancer.

Avastimab 100mg Injection may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.

Chemotherapy remains necessary. Avastimab 100mg Injection is given along with chemotherapy for treating cancer.

Avastimab 100mg Injection may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Avastimab 100mg Injection. Talk to your doctor for more information.

Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.

Avastimab 100mg Injection may increase the incidence of hypertension. Therefore, consult your doctor before taking Avastimab 100mg Injection if you have high blood pressure.

Avastimab 100mg Injection is given intravenously (into a vein) infusion by a healthcare professional. Avastimab 100mg Injection should never be given as an intravenous push or bolus. Do not self-administer.

The duration of treatment with Avastimab 100mg Injection depends on your condition and response to the treatment. Your doctor will decide the length of time, based on its effectiveness and your tolerance. Regular monitoring will guide ongoing treatment.

Chemotherapy targets and destroys rapidly dividing cells, including cancer cells, to stop their growth and spread. While, Avastimab 100mg Injection works by inhibiting the formation of new blood vessels that supply oxygen and nutrients to tumors. Cutting off this blood supply helps shrink the tumor or prevent it from growing further.

A person taking Avastimab 100mg Injection may still require chemotherapy. Avastimab 100mg Injection is often used in combination with chemotherapy to treat certain cancers, as it helps prevent tumor growth by blocking blood vessel formation and improves the effectiveness of chemotherapy.

Avastimab 100mg Injection causes side effects such as constipation, loss of appetite, fever, nose bleeds, change in speech, voice changes/hoarseness, and loss of body weight. Most of these side effects do not require any medical requirements as they will gradually reduce over time. Contact a doctor if these side effects persist for longer durations.